Form 4: Inotiv CFO Beth Taylor Receives Stock and Option Grants

Inotiv's Chief Financial Officer, Beth Taylor, reports the acquisition of restricted stock units and stock options in the company.

Summary

• Beth Taylor, CFO of Inotiv, Inc., filed a Form 4 on August 14, 2024, reporting changes in beneficial ownership.
• On August 10, 2024, Taylor acquired 20,000 shares of common stock through a grant of restricted stock units, vesting fully on June 18, 2026, contingent upon continued employment.
• Taylor also acquired an option to buy 20,000 shares of common stock at an exercise price of $1.61 on August 10, 2024.
• The stock option vests over three years: 40% on June 18, 2025, 30% on June 18, 2026, and 30% on June 18, 2027, subject to continued employment.
• Following these transactions, Taylor directly owns 114,792 shares of Inotiv common stock and options to buy 20,000 shares.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The grant of stock and options is a standard practice and suggests confidence in the company's future performance. The vesting schedules promote long-term alignment with shareholder interests.

Positives

• The grant of restricted stock units and stock options to the CFO aligns her interests with those of the shareholders, incentivizing her to improve the company's performance.
• The vesting schedules for both the stock units and options encourage long-term commitment from the CFO.

Future Outlook

The document does not contain specific forward-looking statements beyond the vesting schedules of the stock and options.

Industry Context

Stock and option grants are a common practice in the industry to incentivize and retain key executives. The specific terms of the grant (vesting schedule, exercise price) are tailored to the company's specific circumstances and strategic goals.

Comparison to Industry Standards

• Stock option grants are a common component of executive compensation packages in the biotech and pharmaceutical services industries.
• Companies like Charles River Laboratories and Envigo (now part of Inotiv) also utilize stock options and restricted stock units to align executive incentives with shareholder value.
• The vesting schedules are fairly standard, with multi-year vesting periods to encourage long-term commitment.

Stakeholder Impact

• Shareholders: The grants align the CFO's interests with those of the shareholders, potentially leading to improved company performance.
• Employees: The grants may have a positive impact on employee morale, as they demonstrate the company's commitment to its leadership team.

Key Dates